Clinical Study
Relationships of Cardiorespiratory Fitness with Metabolic Risk Factors, Inflammation, and Liver Transaminases in Overweight Youths
Table 3
Multivariate regression between metabolic risk factors and VO²Max, using age and % fat mass as covariates.
| | Girls | | Boys | | | F | | | F | | |
| Systolic BP | 1.938 | .129 | | 2.508 | .066 | | Diastolic BP | 0.201 | .896 | | 3.294 | .025 | VO²Max: 0.048 | Fasting Glucose | 1.476 | .226 | | 1.968 | .125 | | Fasting Insulin | 5.683 | .001 | VO²Max: 0.002 | 6.317 | <.0001 | Age: 0.017 | HOMA-IR | 4.530 | .005 | VO²Max: 0.001 | 6.275 | <.0001 | Age: 0.026 | Triglycerides | 2.384 | .073 | | 3.976 | .010 | VO²Max: 0.034 | HDL Cholesterol | 1.055 | .371 | | 3.139 | .029 | Age: 0.039 | LDL Cholesterol | 0.846 | .472 | | 0.930 | .431 | | AST | 1.051 | .373 | | 0.514 | .674 | | ALT | 3.829 | .012 | VO²Max: 0.073 | 2.492 | .065 | | Fibrinogen | 4.21 | .008 | Age: 0.040 % FM: 0.007 | 2.938 | .038 | %FM: 0.018 | Sedimentation rate | 4.077 | .009 | | 4.085 | <.001 | %FM: 0.045 |
|
|
Tanner stage did not significantly enter in any model tested.
|